| | November 20176CIOReviewCopyright © 2017 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.CIOReviewNOVEMBER - 06 - 2017Mailing AddressCIOReview44790 S. Grimmer Blvd Suite 202, Fremont, CA 94538T:510.402.1463, F:510-894-8405 NOVEMBER - 06 - 2017, Vol 06 SE 112 Published by ValleyMedia Inc.To subscribe to CIOReviewVisit www.cioreview.com PHARMA AND LIFE SCIENCES SPECIALCIOReviewEditorial StaffSalesT: 510.996.5123Banu JohnCarolynn WaltersJustin BlackKyle SummersRussell ThomasSam EricssonSherin Matthewsherin@cioreview.comVisualizersAsher BlakeAR RamjithManaging EditorJeevan GeorgePharma and life-sciences industry is in the middle of a constant transformation fuelled by the need to handle ever-growing data, use of modern cloud technology, implementation of agile business models and the requirement to align with the compliance standards. Today the advancements in cloud technology is empowering pharma and life sciences companies to harness relevant insights from data that will help facilitate better decision-making, optimize innovation, and improve efficiency of research and clinical trials.With the huge proliferation of data, companies are also looking at effectively employing machine learning and artificial intelligence (AI) capabilities in their processes. From discovery and development through the entire product lifecycle, AI is starting to shake up the life-sciences industry. Alongside drug discovery, AI can also be used to analyze health data in order to detect and treat diseases at the earliest, taking pharmaceutical companies deeper into the realms of wellness. Given the incredible potential of machine learning, it's no wonder that in last five years, $1.5 billion has been invested in AI start-ups in the pharma and life-sciences space.In this special edition of CIOReview, CIOs from leading pharmaceutical and life-sciences companies share their experiences of leveraging technology to meet challenges in their business environment. We also present to you 20 Most Promising Pharma and Life Sciences Technology Solution Providers - 2017, a list of leading vendors in the space that can help you employ the best-in-breed technologies to ultimately enhance productivity.We trust you enjoy reading this edition.Jeevan George Managing Editoreditor@cioreview.comEditorialThe Right Blend of Intelligence and Insight*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staff
< Page 5 | Page 7 >